20 articles
A new global report finds longevity clinics are scaling fast but lack the standardized frameworks needed to validate their outcomes.
Industry leaders at Milan 2026 say longevity medicine must move beyond hype and deliver measurable, accountable preventive care.
Clearing zombie cells then restoring stem cell activity produced far greater lifespan gains than either approach alone.
An $80M renewal of the Long Life Family Study uncovers genes, proteins, and fitness traits that predict exceptional longevity.
Elysium Health moves beyond supplements into integrated longevity medicine, bundling prescriptions, peptides, and clinical monitoring for 10,000 members.
WashU Medicine's Long Life Family Study renewal uses long-read sequencing to decode why some families consistently escape age-related disease.
Major NIH funding supports research into exceptional longevity families and healthy aging interventions through two landmark grants.
From a massive family study of centenarians to a paradigm shift in how aging is measured, longevity science is evolving fast.
China's first standardized longevity medicine curriculum trains doctors in aging biology, cardiometabolic prevention, and AI-assisted care.
Lifespan.io reviews top rejuvenation research advances including voice-based aging biomarkers and a rapamycin-exercise clinical trial.
New genetic and proteomic findings from centenarian studies uncover biological markers that distinguish the longest-lived humans from the rest of us.
Major NIH grants target centenarian genetics and longevity consortia, signaling a new era of federally funded lifespan research.
An $80M family study, 37 proteins in centenarian blood, and a call to rethink aging as a systems failure — here's what's new.
From an $80M genetics study to a single-injection heart therapy, new research is redefining what drives exceptional human lifespan.
A landmark grant renews the Long Life Family Study, while centenarian blood protein data and new geroscience calls reshape longevity research.
Eric Verdin, Morgan Levine, and Bette Yin Lacroix headline a 100-talk longevity conference covering NAD biology, epigenetic aging, and lifespan extension.
An $80M family study, 37 proteins in centenarian blood, and a call to treat aging as a systems failure converge in new research.
Immorta Bio combines senolytics and stem cell revival with AI to achieve 70%+ lifespan extension in animal models.
A landmark NIH grant renewal will extend research into families with exceptional longevity and add long-read whole-genome sequencing to uncover new genetic clues.
The Long Life Family Study gets a major funding boost to use cutting-edge long-read sequencing on 7,800 centenarian-family genomes.
